Responses
Immune cell therapies and immune cell engineering
Original research
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice
Compose a Response to This Article
Other responses
No responses have been published for this article.